China Urinary Tract Infection Testing Market Size & Outlook

The urinary tract infection testing market in China is expected to reach a projected revenue of US$ 44.1 million by 2030. A compound annual growth rate of 6% is expected of China urinary tract infection testing market from 2024 to 2030.
Revenue, 2023 (US$M)
$29.2
Forecast, 2030 (US$M)
$44.1
CAGR, 2024 - 2030
6.1%
Report Coverage
China

China urinary tract infection testing market, 2018-2030 (US$M)

China

Related Markets

China urinary tract infection testing market highlights

  • The China urinary tract infection testing market generated a revenue of USD 29.2 million in 2023 and is expected to reach USD 44.1 million by 2030.
  • The China market is expected to grow at a CAGR of 6% from 2024 to 2030.
  • In terms of segment, cystitis was the largest revenue generating type in 2023.
  • Pyelonephritis is the most lucrative type segment registering the fastest growth during the forecast period.

Urinary tract infection testing market data book summary

Market revenue in 2023USD 29.2 million
Market revenue in 2030USD 44.1 million
Growth rate6% (CAGR from 2023 to 2030)
Largest segmentCystitis
Fastest growing segmentPyelonephritis
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationUrethritis, Cystitis, Pyelonephritis
Key market players worldwideQiagen NV, Bio-Rad Laboratories Inc, Roche Holding AG, Danaher Corp, Siemens Healthineers AG ADR, Thermo Fisher Scientific Inc, BioMerieux SA, T2 Biosystems Inc, Accelerate Diagnostics Inc, Randox

Other key industry trends

  • In terms of revenue, China accounted for 4.8% of the global urinary tract infection testing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan urinary tract infection testing market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 26.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Urinary Tract Infection Testing Market Companies

Name Profile # Employees HQ Website

China urinary tract infection testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to urinary tract infection testing market will help companies and investors design strategic landscapes.


Cystitis was the largest segment with a revenue share of 41.44% in 2023. Horizon Databook has segmented the China urinary tract infection testing market based on urethritis, cystitis, pyelonephritis covering the revenue growth of each sub-segment from 2018 to 2030.


  • China Urinary Tract Infection Testing Type Outlook (Revenue, USD Million, 2018-2030)
    • Urethritis
    • Cystitis
    • Pyelonephritis
  • China Urinary Tract Infection Testing End Use Outlook (Revenue, USD Million, 2018-2030)
    • General Practitioners (GPs)
    • Urologists
    • Urogynecologists
    • Hospital Laboratories
    • Reference Laboratories
    • Hospital Emergency Departments
    • Urgent Care
    • Others

Reasons to subscribe to China urinary tract infection testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China urinary tract infection testing market databook

  • Our clientele includes a mix of urinary tract infection testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China urinary tract infection testing market , including forecasts for subscribers. This country databook contains high-level insights into China urinary tract infection testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China urinary tract infection testing market size, by type, 2018-2030 (US$M)

China Urinary Tract Infection Testing Market Outlook Share, 2023 & 2030 (US$M)

China urinary tract infection testing market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more